Meanwhile FGFR-specific downstream signaling adaptor, FGFR substrate 2 (FRS2), is overexpressed in liposarcoma and renders these cells sensitive to FGFR inhibitors (Zhang et al., 2013; Hanes et al., 2016). Here, FRS2 is linked to liposarcoma.